{
 "context": "The following article called 'Iovance Biotherapeutics posts 4Q loss' was published on 2018-03-12. The body of the article is as follows:\n    \nSAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Monday reported a loss of $25.9 million in its fourth quarter.\nOn a per-share basis, the San Carlos, California-based company said it had a loss of 36 cents. Losses, adjusted for stock option expense, came to 32 cents per share.\nThe results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 32 cents per share.\nFor the year, the company reported that its loss narrowed to $92.1 million, or $1.41 per share.\nIovance Biotherapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $19.15, more than doubling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA\n\n    The day before the article was published, the stock price of Iovance Biotherapeutics, Inc. was 19.100000381469727 and the day after the article was published, the stock price of Iovance Biotherapeutics, Inc. was ",
 "expected": "17.450000762939453",
 "date": "2018-03-12",
 "ticker": "IOVA",
 "company": "Iovance Biotherapeutics, Inc.",
 "url": "https://www.cnbc.com/2018/03/12/the-associated-press-iovance-biotherapeutics-posts-4q-loss.html"
}